Enteric Disease Testing Market

Global Enteric Disease Testing Market Size (2023 to 2028)

The global enteric disease testing market is estimated to grow at a CAGR of 5.94% during the forecast period. The market size is expected to rise to USD 2.96 billion by 2028 from USD 2.22 billion in 2023.

The body may lose fluids and essential nutrients due to intestinal illnesses. Anorexia, nausea, vomiting, and stomach discomfort are common symptoms of enteric disorders. Enteric diseases, which include parasites, viruses, and bacteria, are brought on by foreign antigens. The most common infections causing intestinal diseases include Salmonella, Shigella, rotavirus, norovirus, E. coli, and Vibro Cholerae. The enteric disease mainly occurs through consuming contaminated food and can be transmitted from one infected person to another. The testing of enteric illnesses is generally carried out by using cultures and observing the samples of the patient's blood, bone marrow, tissue, etc., for any pathogen. It is essential to perform enteric disease testing to cure the diseases caused by these foreign invaders and exercise caution. 

Impact of COVID-19 on the global enteric disease testing market:

Many areas of the world were in an uproar due to the epidemic. The cumulative losses suffered by countless businesses, industries, and organizations in the products and services sectors led to a significant downturn in the economies of multiple countries. Due to the limited delivery and transportation of goods, many corporate go-downs had to close. Lockdowns and quarantines forced the closure of a substantial portion of service businesses. Government relief funds could not cover a sizable percentage of the economic loss, and national unemployment rose. The healthcare sector, which had to deal with an influx of COVID-19 patients and a shortage of supplies and skilled workers, was one of the worst affected industries.

According to predictions, the COVID-19 epidemic will increase consumer anxiety over the security and safety of food products, which could lead to a swift global uptake of testing equipment and facilities. As a result, the need for diagnostics for enteric diseases will increase during the coming years. Furthermore, pandemic conditions brought on by the COVID-19 epidemic would increase demand for rapid tests from food producers and growers to test a sufficient number of samples in a shorter time, boosting supply chain activities and pushing the usage of testing technology.

MARKET DRIVERS:

The demand for early diagnosis of the enteric disease is anticipated to increase due to the increasing prevalence of enteric infections and the cost-effectiveness of technologically enhanced diagnostic equipment leading to a rise in the enteric disease testing market. A classic diagnostic method, like the culture method, required experienced personnel and was arduous and time-consuming. Therefore, Over the past ten years, the market for testing enteric disorders has undergone a revolution thanks to the advent of molecular diagnostics and other diagnostic technologies. 

Increasing rates of death, especially in developing countries, push market growth. For example, 90% of deaths connected to diarrhea are also caused by a lack of access to safe drinking water and basic sanitary facilities. Additionally, 90% of typhoid-related mortality occurs in Asia. Furthermore, growing demand for early detection of various illnesses, increased gastrointestinal disease in developing countries, inadequate laboratory conditions, and shared knowledge are all leading to a spike in cases of enteric infection, pushing the need for a testing market. 

Enteric disease testing is becoming increasingly important as people's preferences for convenience foods change, and they prefer packaged items with preservatives to increase the shelf life of packaged goods. However, these packages of goods can cause problems like food poisoning. Additionally, the post covid world is exceptionally cautious about food safety, and the government initiatives and key market players' investments towards improving healthcare facilities are expected to drive the market growth. 

MARKET RESTRAINTS:

Factors such as the rise in the incidence of undiscovered gastrointestinal illnesses and the lack of patient awareness in emerging countries, along with the high cost of labor and labor-intensive equipment, as well as the necessity for sophisticated laboratory conditions for clinical diagnoses, are primarily hampering the growth of the enteric disease testing market. In addition, the absence of reimbursement legislation in developing nations like China and India, along with the weak regulation of pathogen testing in emerging economies.

This research report on the global enteric disease testing market has been segmented and sub-segmented based on the pathogen, technology, end-user, and region.

Global Enteric Disease Testing Market - By Pathogen Tested:

• Campylobacter
• Listeria
• Salmonella
• E. Coli
• Other Pathogens (Clostridium; Hepatitis A, B, And E; Enterobacteriaceae, Shigella, Norovirus, Rotavirus, And Vibrio)

The E-coli segment is expected to lead the enteric disease testing market during the forecast period due to the prevalence of the diseases caused by e-coli infections. In addition, E-coli is the most prominent cause of enteric diseases, especially in children.

Global Enteric Disease Testing Market - By Technology:

• Rapid
• Convenience-Based
• Immunoassay
• Chromatography & Spectrometry
• Traditional
• Polymerase Chain Reaction (PCR)

Based on technology, the rapid segment is anticipated to lead the market during the forecast period. Therefore, the rapid technology sector is also leading the market. This is because the food industry uses rapid technology to track the number, type, and metabolites of microorganisms that result in food spoilage, preservation, fermentation, safety, and foodborne pathogens.

Global Enteric Disease Testing Market - By End-User:

• Food
  • Meat, Poultry, And Seafood
  • Processed Food
  • Dairy Products
  • Fruits & Vegetables
  • Other Food Products (Includes Nuts, Herbs & Spices, And Cereals &Grain)
• Water

Throughout the projected period, the market is anticipated to be dominated by the food category. Government and public health institutions now closely monitor food quality and move fast to identify, contain, and eradicate outbreaks' causes because of the growth of the food trade.

Global Enteric Disease Testing Market - By Region:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

Geographically, the North American region is forecasted to showcase significant domination among all the regions in the global market during the forecast period owing to the high consumer awareness of nutritious meals and nutrition, rising typhoid prevalence, expensive goods, a crowded market, and a focus on identifying, monitoring, and preventing foodborne illnesses along with the prevalence of packages and canned food consumptions in the countries like the U.S. and Canada. On the other hand, the European market is also fast growing due to a sizable elderly population, substantial levels of technology adoption, supportive government measures, and collaborations and mergers amongst enterprises.

The market in Asia-Pacific and Latin America are expected to be the fastest growing due to the growing public knowledge of testing and infections, the population living in metropolitan areas with gastrointestinal disorders, biomedical research accelerating R&D in the detection and treatment of infectious diseases, and consumer demand for higher-quality healthcare services.

KEY MARKET PLAYERS:

Some of the notable players in the global enteric disease testing market are Diasorin, BioMerieux, Quest Diagnostics, Meridian Biosciences, Bio-Rad Laboratories, B.D.B.D., Alere Inc, Cepheid, Biomerica Inc, Coris Bioconcept, S.G.S. S.A., Intertek Group Plc, Bureau Veritas, A.L.S. Limited, TUV SUD.